feed,title,long_url,short_url
Benzinga,Kiadis receives $9.5 million from the Advanced Regenerative Manufacturing Institute's BioFabUSA Program to fund Kiadis K-NK cell COVID-19 therapy,https://www.benzinga.com/pressreleases/20/09/g17501856/kiadis-receives-9-5-million-from-the-advanced-regenerative-manufacturing-institutes-biofabusa-prog,https://j.mp/2ZBOQHx
